Difelikefalin Impurity 20 represents a minor analog arising during difelikefalin synthesis or oxidation. Structural modification affects hydrophobic balance and peptide folding. Researchers use it to evaluate impurity separation and degradation kinetics. Applications include QC profiling, process-mapping, and structure-property studies.
CAT No: Z10-101-201
Synonyms/Alias:1-(L-phenylalanyl-D-leucyl-D-lysyl)-4-aminopiperidine-4-carboxylic acid
Difelikefalin Impurity 20 is a specialized carbohydrate compound that plays a significant role in the realm of pharmaceutical research and analytical chemistry. As a structurally related impurity of the synthetic peptide difelikefalin, this compound is invaluable for laboratories and researchers focused on drug development, quality control, and pharmacological profiling. Its unique molecular configuration allows for precise analytical studies, enabling a deeper understanding of the parent drug's stability, degradation pathways, and overall chemical behavior. Difelikefalin Impurity 20 is synthesized and characterized to support advanced research needs, offering a reliable reference point for scientists aiming to ensure the integrity and safety of investigational compounds. The availability of such impurities is essential for comprehensive impurity profiling, which is a critical component of modern pharmaceutical development and analytical validation.
Analytical Method Development: In the context of analytical method development, Difelikefalin Impurity 20 serves as a crucial reference standard. Researchers employ this compound to calibrate and validate chromatographic and spectrometric methods, ensuring the accurate detection and quantification of impurities in difelikefalin formulations. Its presence allows for the optimization of analytical protocols, facilitating the differentiation between the main active pharmaceutical ingredient and its related substances. By using Difelikefalin Impurity 20, laboratories can enhance the specificity and sensitivity of their analytical methods, ultimately supporting the rigorous assessment of drug quality throughout the development pipeline.
Stability Studies: Within stability studies, the impurity is utilized to investigate the degradation profile of difelikefalin under various environmental conditions. By intentionally introducing Difelikefalin Impurity 20 into stability samples, researchers can monitor its formation and behavior over time, thereby elucidating the mechanisms of chemical degradation and transformation. This approach aids in predicting the shelf life of pharmaceutical products and in identifying critical factors that may impact product efficacy and safety during storage and transportation.
Process Development and Optimization: In pharmaceutical process development, Difelikefalin Impurity 20 provides valuable insights into synthetic routes and purification strategies. Its identification and quantification help chemists refine manufacturing processes, minimize impurity formation, and optimize purification steps. By understanding the origins and fate of such impurities, process engineers can implement targeted modifications to enhance product yield and purity, contributing to more efficient and reproducible production cycles.
Pharmacological Research: The presence of this impurity also supports pharmacological research by enabling the study of structure-activity relationships. Scientists investigate Difelikefalin Impurity 20 to assess its potential biological effects, receptor interactions, and metabolic pathways relative to the parent compound. Such studies are instrumental in distinguishing the pharmacodynamic and pharmacokinetic properties of difelikefalin from those of its impurities, thereby informing the design of safer and more effective therapeutic agents.
Reference Material for Regulatory Submissions: As a well-characterized impurity, Difelikefalin Impurity 20 functions as a reference material for regulatory documentation and submissions. Researchers utilize it to demonstrate comprehensive impurity profiling and risk assessment in support of investigational new drug applications and other scientific dossiers. Its inclusion in analytical studies underscores a commitment to transparency and thoroughness in pharmaceutical research, fostering greater confidence in the quality and consistency of difelikefalin-based products.
Difelikefalin Impurity 20 stands as an indispensable tool for a broad spectrum of scientific applications, from analytical method validation and stability testing to process optimization and pharmacological investigation. Its role as a reference standard and research material extends beyond routine laboratory practice, contributing to the advancement of pharmaceutical science and the development of safer, higher-quality drug products. By integrating this impurity into their research workflows, scientists can achieve a more comprehensive understanding of difelikefalin and its related substances, ultimately supporting innovation and excellence in the field of drug discovery and development.
4. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More